Adverse drug reactions resulting from COVID-19 treatment in university members

Descripción del Articulo

Objective: To analyze the extent to which members of the community of a private university report the presentation of adverse drug reactions related to COVID-19 pharmacotherapy. Material and Methods: Quantitative approach, cross-sectional descriptive type, non-experimental design, the sample was 159...

Descripción completa

Detalles Bibliográficos
Autores: Mendoza Gutierrez , Lizzy Jeanette, Andamayo Flores , Diana Esmeralda, Calle Vilca , Mónica Alejandra, Calle Vilca , Luis Alejandro
Formato: artículo
Fecha de Publicación:2023
Institución:Universidad Privada de Huancayo Franklin Roosevelt
Repositorio:Visionarios en ciencia y tecnología
Lenguaje:español
OAI Identifier:oai:revistas.uroosevelt.edu.pe:article/111
Enlace del recurso:https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111
Nivel de acceso:acceso abierto
id REVROOS_480170e2a1954cc8f3bef4099d0cbc32
oai_identifier_str oai:revistas.uroosevelt.edu.pe:article/111
network_acronym_str REVROOS
network_name_str Visionarios en ciencia y tecnología
repository_id_str
dc.title.none.fl_str_mv Adverse drug reactions resulting from COVID-19 treatment in university members
Reacciones adversas medicamentosas resultado del tratamiento de COVID-19 en miembros de una universidad
title Adverse drug reactions resulting from COVID-19 treatment in university members
spellingShingle Adverse drug reactions resulting from COVID-19 treatment in university members
Mendoza Gutierrez , Lizzy Jeanette
title_short Adverse drug reactions resulting from COVID-19 treatment in university members
title_full Adverse drug reactions resulting from COVID-19 treatment in university members
title_fullStr Adverse drug reactions resulting from COVID-19 treatment in university members
title_full_unstemmed Adverse drug reactions resulting from COVID-19 treatment in university members
title_sort Adverse drug reactions resulting from COVID-19 treatment in university members
dc.creator.none.fl_str_mv Mendoza Gutierrez , Lizzy Jeanette
Andamayo Flores , Diana Esmeralda
Calle Vilca , Mónica Alejandra
Calle Vilca , Luis Alejandro
author Mendoza Gutierrez , Lizzy Jeanette
author_facet Mendoza Gutierrez , Lizzy Jeanette
Andamayo Flores , Diana Esmeralda
Calle Vilca , Mónica Alejandra
Calle Vilca , Luis Alejandro
author_role author
author2 Andamayo Flores , Diana Esmeralda
Calle Vilca , Mónica Alejandra
Calle Vilca , Luis Alejandro
author2_role author
author
author
description Objective: To analyze the extent to which members of the community of a private university report the presentation of adverse drug reactions related to COVID-19 pharmacotherapy. Material and Methods: Quantitative approach, cross-sectional descriptive type, non-experimental design, the sample was 159 members of the university community, stratified probabilistic sampling, the technique was a virtual survey, the instrument was a questionnaire made with Google Forms; the results were expressed as mean, standard deviation, percentage frequency, and for the statistical analysis the following tests were used: chi square and 95% confidence interval with a significance level 0.05. Results: most of the participants were female (63.32%), married (59.12%) and with a mean age of 44.46 years; most of them were teachers (50.31%), from the School of Pharmaceutical Sciences and Biochemistry; 44.65% (71 persons) contracted the covid-19 disease; 94.37% (67 persons) were treated at home and only 2.82% had to go to the hospital for treatment. 82%, had to resort to the hospital; currently 100% are vaccinated; 100% took medication, highlighting the use of antibacterials with 27.65%; 49.30% of the people who became ill manifested adverse events, within these stand out colic (34.04%) and stomach discomfort (29.79%), being the gastrointestinal system most affected. Conclusions: Approximately half of the community members of a Private university presented adverse drug reactions related to COVID-19 pharmacotherapy, with colic being the main RAM.
publishDate 2023
dc.date.none.fl_str_mv 2023-04-28
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111
10.47186/visct.v7i1.111
url https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111
identifier_str_mv 10.47186/visct.v7i1.111
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111/180
https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111/188
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Universidad Privada de Huancayo Franklin Roosevelt
publisher.none.fl_str_mv Universidad Privada de Huancayo Franklin Roosevelt
dc.source.none.fl_str_mv Visionarios en ciencia y tecnología; Vol. 7 Núm. 1 (2022): Enero - Junio; 54-62
2708-6372
2308-2496
reponame:Visionarios en ciencia y tecnología
instname:Universidad Privada de Huancayo Franklin Roosevelt
instacron:ROOSEVELT
instname_str Universidad Privada de Huancayo Franklin Roosevelt
instacron_str ROOSEVELT
institution ROOSEVELT
reponame_str Visionarios en ciencia y tecnología
collection Visionarios en ciencia y tecnología
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846155756718522368
spelling Adverse drug reactions resulting from COVID-19 treatment in university membersReacciones adversas medicamentosas resultado del tratamiento de COVID-19 en miembros de una universidad Mendoza Gutierrez , Lizzy JeanetteAndamayo Flores , Diana EsmeraldaCalle Vilca , Mónica AlejandraCalle Vilca , Luis AlejandroObjective: To analyze the extent to which members of the community of a private university report the presentation of adverse drug reactions related to COVID-19 pharmacotherapy. Material and Methods: Quantitative approach, cross-sectional descriptive type, non-experimental design, the sample was 159 members of the university community, stratified probabilistic sampling, the technique was a virtual survey, the instrument was a questionnaire made with Google Forms; the results were expressed as mean, standard deviation, percentage frequency, and for the statistical analysis the following tests were used: chi square and 95% confidence interval with a significance level 0.05. Results: most of the participants were female (63.32%), married (59.12%) and with a mean age of 44.46 years; most of them were teachers (50.31%), from the School of Pharmaceutical Sciences and Biochemistry; 44.65% (71 persons) contracted the covid-19 disease; 94.37% (67 persons) were treated at home and only 2.82% had to go to the hospital for treatment. 82%, had to resort to the hospital; currently 100% are vaccinated; 100% took medication, highlighting the use of antibacterials with 27.65%; 49.30% of the people who became ill manifested adverse events, within these stand out colic (34.04%) and stomach discomfort (29.79%), being the gastrointestinal system most affected. Conclusions: Approximately half of the community members of a Private university presented adverse drug reactions related to COVID-19 pharmacotherapy, with colic being the main RAM.Objetivo: analizar en qué medida los miembros de la comunidad de una universidad Privada manifiestan la presentación de reacciones adversas medicamentosas relacionadas a la farmacoterapia del COVID-19. Material y métodos: Enfoque cuantitativo, tipo descriptivo transversal, diseño no experimental, la muestra fue de 159 miembros de la comunidad universitaria, muestreo probabilístico estratificado, la técnica fue una encuesta virtual, el instrumento un cuestionario realizado con Google Forms; los resultados se expresaron en media, desviación estándar, frecuencia porcentual, y para el análisis estadístico se empleará las pruebas de: chi cuadrado y el intervalo de confianza al 95% con un nivel de significancia 0,05. Resultados: la mayor participación fue de personas del sexo femenino (63,32%), casadas (59,12%) y con una edad media de 44,46 años; siendo en mayor número docentes (50,31%), de la Escuela de Ciencias Farmacéuticas y Bioquímica; el 44,65% (71 personas), contrajo la enfermedad covid-19; el 94,37% (67 personas), llevó su tratamiento en casa y solo el 2,82%, tuvo que recurrir al hospital; en la actualidad el 100% están vacunadas; el 100% tomó medicamentos, destacando el uso de antibacterianos con 27,65%; el 49,30% de las personas que enfermaron manifestaron eventos adversos, dentro de estos destacan los cólicos (34,04%) y molestias estomacales (29,79%), siendo el sistema gastrointestinal más afectado. Conclusiones: Aproximadamente la mitad de los miembros de la comunidad de una universidad Privada presentaron reacciones adversas medicamentosas relacionadas a la farmacoterapia del COVID-19, siendo los cólicos la principal RAM.Universidad Privada de Huancayo Franklin Roosevelt2023-04-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/11110.47186/visct.v7i1.111Visionarios en ciencia y tecnología; Vol. 7 Núm. 1 (2022): Enero - Junio; 54-622708-63722308-2496reponame:Visionarios en ciencia y tecnologíainstname:Universidad Privada de Huancayo Franklin Rooseveltinstacron:ROOSEVELTspahttps://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111/180https://revistas.uroosevelt.edu.pe/index.php/VISCT/article/view/111/188Derechos de autor 2023 Lizzy Jeanette Mendoza Gutierrez , Diana Esmeralda Andamayo Flores , Mónica Alejandra Calle Vilca , Luis Alejandro Calle Vilca https://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessoai:revistas.uroosevelt.edu.pe:article/1112023-04-28T17:13:51Z
score 13.135628
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).